• Japanese
  • Korean
  • Chinese
Cover Image

OTC market in Central and Eastern Europe 2011

  • Published:
  • 341 Pages
  • PMR

Abstract

image1

The report is a complex analysis of OTC drug and dietary supplement markets in eight countries in the region:

  • Russia
  • Poland
  • Ukraine
  • Romania
  • the Czech Republic
  • Hungary
  • Bulgaria
  • Slovakia.

It analyses the market value in particular countries, as well as in the whole CEE region and pays particular attention to such information as OTC drug market value, dietary supplement market value, share of OTC in the total market, best-selling OTC products, leading OTC manufacturers, and non-pharmacy and online sales of OTC products.

The publication also contains forecasts up to 2013 for OTC drug/product markets in particular countries as well as for the whole region, prepared by a team of pharmaceutical market analysts and PMR's economy experts. The report is complemented with the analysis of distribution segments in particular countries. It is a unique publication which presents all the important information regarding the OTC product market in the CEE region on more than 300 pages.

Key topics covered:

  • best selling OTC drugs in individual countries
  • best selling dietary supplements in individual countries
  • leading OTC drug manufacturers in individual countries
  • profiles of leading regional OTC manufacturers
  • leading dietary supplement manufacturers in individual countries
  • OTC drug market value 2007-2013 in individual countries
  • dietary supplements market value in individual countries
  • share of OTC in total pharmacy sales in individual countries
  • sales structure of OTC products in pharmacy sales in individual countries
  • regulations regarding non-pharmacy sales of OTC products in individual countries
  • regulations regarding online sales of OTC products in individual countries
  • largest advertisers in the OTC segment in individual countries
  • largest pharmacy chains in individual countries
  • largest wholesalers in individual countries
  • main events and trends in individual countries
  • comparative analysis of OTC market value, share of OTC as a proportion of the entire market and share of dietary supplements as a proportion of the entire market
  • consumer behaviours regarding OTC product intake in individual countries
  • epidemiological trends.

When will the report prove useful?

  • when starting a business on the OTCmarket in CEE
  • when developing OTC products sales in CEE
  • when analysing competitors
  • when analysing the market saturation
  • when developing OTC products portfolio in a particular CEE country.

Report strengths:

  • all information regarding the OTC products segment in CEE in one place
  • comparative analysis of OTC product markets in 8 countries
  • the report provides broad range of historical data as it is its third edition
  • development forecasts for 2011-2013.

Find answers for the following questions:

  • In which country is the OTC market the largest?
  • In which country has the OTC market the highest growth potential?
  • Which CEE country has the " friendliest" environment for OTC products?
  • In which country is the OTC market profoundly saturated?
  • What are the strategies OTC manufacturers introduce into the market in CEE?

This report is adressed to:

  • the senior management of OTC companies active in the region
  • pharmaceutical wholesalers and distributors
  • non-pharmacy and on-line drug distributors
  • research and analytical institutions
  • embassies and other government institutions.

Companies mentioned in this report:

Actavis, Akvion, Bayer, Beres, Berlin-Chemie/Menarini, Boehringer Ingelheim, Bristol-Myers Squibb, Diod, Evalar, Farmak, Gedeon Richter, GlaxoSmithKline, Johnson & Johnson, Maspex, Novartis, NP Pharma, Ozone Laboratories, Pfizer, Pharmstandard, Reckitt Benckiser, RIA Panda, Sandoz, Sanofi, Sopharma, Stada, Teva, US Pharmacia, Walmark.

Extract from this report

  • According to our forecasts, in the next three years the most attractive of the analysed markets in the region, taking into account forecasted market growth, will be Bulgaria.
  • According to our forecasts, in 2011 the OTC market in Central and Eastern Europe will grow by close to 10% in real terms. In 2012 it will see a positive growth rate of more than 9%, whereas in 2013 it will expand by around 8%.

Market commentary by expert

According to our estimates, in 2010 the OTC market in the CEE region was worth some € 10.7bn, which represented an increase of approx. 13% y-o-y in euro terms. A half was generated by Russia. In 2010, Poland was the second largest OTC market in the region, with a share in total sales of around 23%. Ukraine accounted for around 7% of all OTC business on the CEE market. According to our forecasts, between 2011 and 2013 the market will expand by around 9% on average per annum. Bulgaria and Ukraine will be the fastest developing markets in the region in the analysed period. Agnieszka Skonieczna, Pharmaceutical Market Analyst

Table of Contents

I.Report methodology

II.Executive summary

III.OTC market in CEE countries

  • Comparative analysis of OTC markets in CEE region
  • Share of individual OTC markets in 2010
  • Per capita OTC spending in CEE countries
  • Value of OTC market in CEE countries 2008-2013
  • Average CAGR for OTC markets in CEE countries 2009-2010 and 2011-2013
  • Russia
  • Main trends and events on OTC market
  • OTC market value
  • OTC market value by distribution channel
  • OTC market value by product status (drugs vs. dietary supplements)
  • Share of OTC as a proportion of the pharmaceutical market
  • Value of OTC drug market between 2008 and 2013
  • Value of dietary supplement market between 2008 and 2013
  • OTC product market by therapeutic category
  • Prices of OTC products
  • Best-selling OTC products
  • Poland
  • Main trends and events on OTC market
  • OTC market value
  • OTC market value by distribution channel
  • OTC market value by product status (drugs vs. dietary supplements)
  • Share of OTC as a proportion of the pharmaceutical market
  • Value of OTC product market between 2008 and 2013
  • Value of dietary supplement market
  • OTC products market by therapeutic category
  • Prices of OTC products
  • Switch from Rx to OTC
  • Best-selling OTC products
  • Ukraine
  • Main trends and events on OTC market
  • OTC market value
  • OTC market value by product status (drugs vs. dietary supplements)
  • Share of OTC as a proportion of the pharmaceutical market
  • Value of OTC drug market between 2008 and 2013
  • Value of dietary supplement market between 2008 and 2013
  • Prices of OTC products
  • Switch from Rx to OTC
  • Best-selling OTC products
  • Czech Republic
  • Main trends and events on OTC market
  • OTC market value
  • OTC market value by distribution channel
  • OTC drug market by volume
  • Share of OTC as a proportion of the pharmaceutical market
  • Value of OTC product market between 2008 and 2013
  • Value of dietary supplement market
  • OTC product market by therapeutic category
  • Prices of OTC products
  • Switch from Rx to OTC
  • Best-selling OTC products
  • Romania
  • Main trends and events on OTC market
  • OTC market value
  • OTC market value by distribution channel
  • OTC market value by product status (drugs vs. dietary supplements)
  • Share of OTC as a proportion of the pharmaceutical market
  • Value of OTC product market between 2006 and 2013
  • Value of dietary supplement market between 2005 and 2013
  • OTC drug market by therapeutic category
  • Prices of OTC products
  • Switch from Rx to OTC
  • Best-selling OTC products
  • Hungary
  • Main trends and events on OTC market
  • OTC market value
  • OTC market value by distribution channel
  • OTC market value by product status (drugs vs. dietary supplements)
  • Share of OTC as a proportion of the pharmaceutical market
  • Value of OTC product market between 2008 and 2013
  • Value of dietary supplement market
  • OTC drug market by therapeutic category
  • Prices of OTC products
  • Switch from Rx to OTC
  • Best-selling OTC products
  • Bulgaria
  • Main trends and events on OTC market
  • OTC market value
  • OTC market value by distribution channel
  • OTC market value by product status (drugs vs. dietary supplements)
  • Share of OTC as a proportion of the pharmaceutical market
  • Value of OTC product market between 2009 and 2013
  • Value of dietary supplement market
  • OTC drug market by therapeutic categories
  • Prices of OTC products
  • Best-selling OTC products
  • Slovakia
  • Main trends and events on OTC market
  • OTC market value
  • OTC market value by distribution channel
  • Share of OTC as a proportion of the pharmaceutical market
  • Value of OTC product market between 2006 and 2012
  • OTC drug market by therapeutic category
  • Prices of OTC products
  • Switch from Rx to OTC
  • Best-selling OTC products

IV.Advertising of OTC products in CEE countries

  • Russia
  • Legal framework
  • Spending on OTC advertising
  • Poland
  • Legal framework
  • Spending on OTC advertising
  • TV advertising
  • Radio advertising
  • Internet advertising
  • Outdoor advertising
  • Ukraine
  • Legal framework
  • Spending on OTC advertising
  • TV advertising
  • Radio advertising
  • Press advertising
  • Internet advertising
  • Czech Republic
  • Legal framework
  • Spending on OTC advertising
  • TV advertising
  • Radio advertising
  • Press advertising
  • Advertising on other media
  • Romania
  • Legal framework
  • Spending on OTC advertising
  • Hungary
  • Legal framework
  • Spending on OTC advertising
  • Bulgaria p. 158
  • Legal framework
  • Spending on OTC advertising
  • Slovakia p. 159
  • Legal framework
  • Spending on OTC advertising

V.Key manufacturers

  • Profiles of selected local manufacturers on OTC market in CEE
  • Key players in selected CEE countries
  • Russia
  • Poland1
  • Ukraine
  • Czech Republic
  • Romania
  • Hungary
  • Bulgaria
  • Slovakia

VI.Distribution

  • Russia
  • Pharmaceutical wholesalers
  • Segment profile
  • Selected key players
  • Pharmacy distribution
  • Segment profile
  • Selected key players
  • Non-pharmacy sales
  • Online sales
  • Poland
  • Pharmaceutical wholesalers
  • Segment profile
  • Selected key players
  • Pharmacy distribution
  • Segment profile
  • Selected key players
  • Non-pharmacy sales
  • Online sales
  • Ukraine
  • Pharmaceutical wholesalers
  • Segment profile
  • Selected key players
  • Pharmacy distribution
  • Segment profile
  • Selected key players p
  • Non-pharmacy sales
  • Online sales
  • Czech Republic
  • Pharmaceutical wholesalers
  • Segment profile
  • Selected key players
  • Pharmacy distribution
  • Segment profile
  • Selected key players
  • Non-pharmacy sales
  • Online sales
  • Romania
  • Pharmaceutical wholesalers
  • Segment profile
  • Selected key players
  • Pharmacy distribution
  • Segment profile
  • Selected key players
  • Non-pharmacy sales
  • Online sales
  • Hungary
  • Pharmaceutical wholesalers
  • Segment profile
  • Selected key players
  • Pharmacy distribution
  • Segment profile
  • Selected key players
  • Non-pharmacy sales
  • Online sales
  • Bulgaria
  • Pharmaceutical wholesalers
  • Segment profile
  • Selected key players
  • Pharmacy distribution
  • Segment profile
  • Selected key players
  • Non-pharmacy sales
  • Online sales
  • Slovakia
  • Pharmaceutical wholesalers
  • Segment profile
  • Selected key players
  • Pharmacy distribution
  • Segment profile
  • Selected key players
  • Non-pharmacy sales
  • Online sales p. 307
  • Comparative analysis of distribution in CEE
  • Non-pharmacy sales
  • Online sales
  • Pharmacy distribution

VII.Factors influencing OTC market in CEE countries

  • Macroeconomic and demographic indicators
  • GDP growth
  • Inflation rates
  • Labour market
  • Unemployment rates
  • Wage levels
  • Population
  • Epidemiological trends
  • Life expectancy at birth
  • Weight problems
  • Alcohol consumption
  • Smoking prevalence

VIII.List of graphs

IX.List of tables

X.About PMR

List of graphs

  • 1.Share of individual OTC markets as a proportion of total OTC market in CEE, 2010
  • 2.Value (€ bn) and y-o-y change of the OTC products market in CEE, 2008-2013
  • 3.Share of individual OTC markets as a proportion of total OTC market in CEE, 2010
  • 4.Per capita spending on OTC products (€ ) in CEE countries, 2010
  • 5.Per capita spending on dietary supplements (€ ) in CEE countries, 2010
  • 6.Value (€ bn) and y-o-y change of the OTC products market in CEE, 2008-2013
  • 7.Average CAGR for OTC markets in the analysed CEE countries for years 2009-2010
  • 8.Average CAGR for OTC markets in the analysed CEE countries for years 2011-2013
  • 9.Market share of drugs and dietary supplements as a proportion of the out-of-the-pocket pharmacy market for plant-based liver protector products in Russia, by value and volume, Q1-Q3 2010
  • 10.Pharmacy sales of OTC products in Russia, by product status, 2010
  • 11.Total sales of OTC products in Russia, by product status, 2010
  • 12.Share of OTC drugs as a proportion of the Russian pharmaceutical market, by value, 2010
  • 13.Share of OTC drugs as a proportion of the Russian out-of-the-pocket market, by value and volume, 2008-2010
  • 14.Share of OTC drugs as a proportion of Russian drug imports, by value and volume, 2009 and 2010 32
  • 15.Share of OTC drugs as a proportion of the Russian generic drug market, by value, 2008-2010
  • 16.Value (RUB bn) and y-o-y change in the OTC drug market in Russia, 2008-2013
  • 17.Value (RUB bn) and y-o-y change in the dietary supplement market in Russia, 2008-2013
  • 18.OTC drug market in Russia, by main product categories (€ m), 2010
  • 19.Dietary supplement pharmacy market in Russia, by main product categories (€ m), 2010
  • 20.Market share of main dietary supplement categories in Russia, by value, 2010
  • 21.Average prices of OTC drugs per package in Russia ($), 2002-Q1 2011
  • 22.Average prices of dietary supplements per package in Russia ($), 2008-Q1 2011
  • 23.Price ranges of dietary supplements in Russia, by value, imported and domestic, 2010
  • 24.Market share of top 10 best selling OTC drugs in Russia, by sales value, 2010
  • 25.Sales value of top 10 best selling dietary supplements in Russia (€ m), 2010
  • 26.Market share of top 10 best selling dietary supplements in Russia, by sales value, 2010
  • 27.Value of Polish dermocosmetics market (PLN m) and y-o-y change, 2008-2011
  • 28.OTC product market in Poland, by sales channel, 2010
  • 29.Pharmacy sales of OTC products in Poland, by product status, 2010
  • 30.Non-pharmacy sales of OTC products in Poland, by product status, 2010 49
  • 31.OTC drugs market in Poland, by sales channel, 2010
  • 32.Total sales of OTC products in Poland, by product status, 2010
  • 33.Share of OTC drugs as a proportion of the Polish pharmaceutical market, by value, 2010
  • 34.Value (PLN bn) and y-o-y change in the OTC product market in Poland, 2008-2013
  • 35.Value (PLN m) and y-o-y change in the dietary supplement market in Poland, 2005-2012
  • 36.OTC product market in Poland, by main product categories (€ m), 2010
  • 37.The most popular categories of OTC products in Poland, 2010
  • 38.Value shares of individual therapeutic categories in the non-pharmacy market of medicines in Poland, 2010
  • 39.Shares of individual therapeutic categories of medicines in the number of products in hypermarkets in Poland, 2011
  • 40.Shares of individual therapeutic categories of dietary supplements in the number of products in hypermarkets in Poland, 2011
  • 41.Price per package and pharmacy margins imposed on OTC products in Poland, 2008-2010
  • 42.Average prices of OTC products per package (PLN) and y-o-y change in Poland, 2002-H1 2011
  • 43.The number of Rx-OTC status changes in Poland, 2008-2010
  • 44.Best-selling product categories available from online pharmacies in Poland, 2010
  • 45.Percentage of OTC and Rx prescriptions in Ukraine, by doctor's specialisation, November 2010
  • 46.Share of individual ATC categories as a proportion of the list of OTC drugs approved in Ukraine, by number of items, December 2010
  • 47.Factors which influence drug purchases at pharmacies in Ukraine, 2011
  • 48.Frequency of OTC drug purchases in Ukraine, 2011
  • 49.Pharmacy sales of OTC products in Ukraine, by product category (UAH m), 2007-2010
  • 50.Pharmacy sales of OTC products in Ukraine, by product category ($ m), 2007-2010
  • 51.Pharmacy OTC product market in Ukraine ($ m), by quarter, and y-o-y increase, Q1 2009-Q4 2010
  • 52.Pharmacy sales of OTC products in Ukraine, by product category (m packages), 2007-2010
  • 53.Year-on-year change in OTC drug and dietary supplement value and volume in Ukraine, in comparison with other product categories, H1 2011
  • 54.Share of OTC drugs as a proportion of the Ukrainian pharmaceutical market, by value, 2010
  • 55.Value (UAH m) and y-o-y change in the OTC drug market in Ukraine, 2008-2013
  • 56.Value of dietary supplement pharmacy sales in Ukraine (UAH m), by foreign and domestic products, 2008-2010
  • 57.Volume of dietary supplement pharmacy sales in Ukraine (m packages), by foreign and domestic products, 2008-2010
  • 58.Value (UAH m) and y-o-y change in the dietary supplement market in Ukraine, 2008-2013
  • 59.Average prices of OTC drugs per package in Ukraine ($), 2007-2010
  • 60.Average prices of cosmetics per package in Ukraine ($), 2007-2010
  • 61.Average prices of dietary supplements per package in Ukraine ($), 2007-2010
  • 62.Factors which influence OTC drug purchases in the Czech Republic, 2011
  • 63.Overweight and obesity of adults in the Czech Republic (% of total population), 2000, 2005, 2008 and 2010
  • 64.Number of OTC drug packages sold in the Czech Republic (million), 2006-Q1 2011
  • 65.Share of OTC products as a proportion of the Czech pharmaceutical market, by value, 2010
  • 66.Value (CZK bn) and y-o-y change the OTC product market in the Czech Republic, 2008-2013
  • 67.OTC product market in the Czech Republic, by main product categories (€ m), 2010
  • 68.Boehringer Ingelheim sales revenues by product groups in Romania (RON m), 2009 and 2010
  • 69.Antibiotice Iasi financial results (RON m), H1 2010 and H1 2011
  • 70.Pharmacy sales of OTC products in Romania, by product status, 2010 93
  • 71.Share of OTC products as a proportion of the Romanian pharmaceutical market, by value, 2010
  • 72.Value (RON m) and y-o-y change in the OTC products market in Romania, 2006-2013
  • 73.Value (RON m) and y-o-y change in the dietary supplement market in Romania, 2005-2013
  • 74.OTC drug market in Romania, by main product categories (€ m), 2010
  • 75.Opinions about OTC drugs in Hungary (%), 2009
  • 76.Opinions about dietary supplements in Hungary (%), 2009
  • 77.Influence of particular types of advertisements on Hungarians' drug purchases, Q3 2010
  • 78.Influence of particular types of advertisements on Hungarians' health and beauty products purchases, Q3 2010
  • 79.Knowledge of expression " functional/curative food" in Hungary, January 2011
  • 80.OTC product market in Hungary, by sales channel, 2010
  • 81.Pharmacy sales of OTC products in Hungary, by product status, 2010
  • 82.Non-pharmacy sales of OTC products in Hungary, by product status, 2010
  • 83.Total sales of OTC products in Hungary, by product status, 2010
  • 84.Share of OTC products as a proportion of the Hungarian pharmaceutical market, by value, 2010
  • 85.Value (HUF bn) and y-o-y change in the OTC product market in Hungary, 2008-2013
  • 86.OTC drug market in Hungary, by main product categories (€ m), 2010
  • 87.Market share of main categories of OTC cold products as a proportion of non-pharmacy sales Hungary, by value, September-December 2009 and 2010
  • 88.Market share of various pharmaceutical forms of OTC cold products as a proportion of pharmacy and non-pharmacy sales in Hungary, by value, September-December 2010
  • 89.Average consumer price per package of main categories of OTC cold products in Hungary (HUF), pharmacy sales, September-December 2009 and 2010
  • 90.Average price per package of selected best-selling analgesics in Hungary (HUF), H2 2010
  • 91.Most popular groups of dietary supplements used by Bulgarians, 2011
  • 92.Estimate of OTC product market in Bulgaria, by sales channel, 2010
  • 93.OTC pharmacy product market in Bulgaria by product category, by value, 2010
  • 94.OTC pharmacy product market in Bulgaria by product category, by volume, 2010
  • 95.Estimated non-pharmacy sales of OTC products in Bulgaria, by product status, 2010
  • 96.Estimated total sales of OTC products in Bulgaria, by product status, 2010
  • 97.Estimated share of OTC drugs as a proportion of the Bulgarian pharmaceutical market, by value, 2010
  • 98.Value (BGN m) and y-o-y change in the OTC product market in Bulgaria, 2009-2013
  • 99.Sales value and volume of dietary supplement pharmacy sales in Bulgaria, 2009-2010
  • 100.OTC drug market in Bulgaria, by main product categories (€ m), 2010
  • 101.Average price per product package of selected leading OTC manufacturers in Bulgaria (BGN), 2010
  • 102.Factors which influenced OTC drug purchases in Slovakia, September 2010
  • 103.Share of OTC products as a proportion of the Slovak pharmaceutical market, by value, 2010
  • 104.Value (€ m) and y-o-y change in the OTC product market in Slovakia, 2008-2013
  • 105.OTC drug market in Slovakia, by main product categories (€ m), 2010
  • 106.Average price per drug package of selected leading OTC manufacturers in Slovakia (€ ), 2010 and H1 2011
  • 107.Average price per drug package of selected leading OTC drugs in Slovakia (€ ), H1 2011
  • 108.Total spending on advertising in Russia ($ m) and y-o-y change, healthcare and pharmaceuticals, 2008-2010
  • 109.Breakdown of spending on advertising in Russia, by advertising channel, healthcare and pharmaceuticals, 2008-2010
  • 110.10 leading TV advertisers of OTC drugs and dietary supplements in Russia, by amount spent, 2010
  • 111.Diod's advertising spending in Russia, by media category, 2007-2010 137
  • 112.Shares of individual media in advertising spending of the pharmaceutical industry in Poland, H1 2011
  • 113.Spending on TV advertising of the largest advertisers in the pharmaceutical industry in Poland (PLN m), 2009-H1 2011
  • 114.Spending of pharmaceutical companies on radio advertising in Poland (PLN m), January-February 2010-2011
  • 115.Spending on outdoor advertising (PLN '000) and change in the pharmaceutical sector in Poland, 2006-Q1 2011
  • 116.Total spending on drug advertising in Ukraine (UAH m) and y-o-y change, 2008-January-July 2011
  • 117.Breakdown of spending on drug advertising in Ukraine, by advertising channel, 2008 - January-July 2011
  • 118.Breakdown of spending on TV drug advertising in Ukraine, by TV channel, 2010
  • 119.10 leading TV advertisers of OTC drugs in Ukraine, by amount spent, 2010
  • 120.Top 10 brands of OTC drugs in Ukraine in terms of TV advertising spending, by amount spent, 2010
  • 121.Top 10 OTC products in Ukraine in terms of internet advertising spending, by amount spent, 2010
  • 122.Top 10 OTC products in Ukraine in terms of internet advertising spending, by amount spent, Q1 2011
  • 123.Estimated total spending on OTC product advertising in the Czech Republic (€ m), 2009-H1 2011
  • 124.Advertising spending in the pharmaceutical industry in the Czech Republic, by medium, 2010
  • 125.Number of drug advertising permits issued by the National Drug Agency in Romania, 2008-2010
  • 126.Shares of main kinds of advertising as a proportion of the drug advertising budgets in Romania, 2010
  • 127.Leading TV advertisers of OTC products in Bulgaria (BGN m), by amount spent, 2009-2010
  • 128.Krka Group organisation chart, 2011
  • 129.Krka global revenues and net profit (€ m), 2006-2011
  • 130.Krka global sales, by region, 2010
  • 131.Krka sales in selected CEE countries (€ m), 2010 and H1 2011
  • 132.Krka global OTC sales, by product groups, 2010 165
  • 133.Gedeon Richter global revenues and net profit (€ m), 2006-H1 2011
  • 134.Gedeon Richter global pharmaceutical sales, by country, 2010
  • 135.Pharmstandard sales revenues and net profit (€ m), 2005-H1 2011
  • 136.Share of OTC products as a proportion of Pharmstandard sales revenues, 2010
  • 137.Top 10 Pharmstandard OTC brands, by value, 2010
  • 138.Sopharma global revenues and net profit (€ m), 2008-H1 2011
  • 139.Sopharma export sales, by country and region, Q3 2010
  • 140.US Pharmacia global sales revenues and net profit (€ m), 2004-2009
  • 141.Walmark global turnover (€ m) and y-o-y change, 2003/2004-2010/2011
  • 142.Walmark turnover (€ m) and y-o-y change in Romania, 2006-2011
  • 143.Market share of top 10 manufacturers of OTC drugs in Russia, by value, 2010
  • 144.Sales value of top 10 manufacturers of dietary supplements in Russia (€ m), 2010
  • 145.Market share of top 10 manufacturers of dietary supplements in Russia, by value, 2010
  • 146.Estimated market share of selected top manufacturers of OTC drugs in Poland, by value, 2010
  • 147.Estimated market share of selected top manufacturers of dietary supplements in Poland, by value, 2010
  • 148.Market share of top 10 manufacturers of OTC products in Ukraine, by value, 2010
  • 149.Share of top 10, 25 and 45 companies as a proportion of revenue on the OTC market in Ukraine, by value, 2009-2010
  • 150.Market share of selected top manufacturers of OTC drugs in Ukraine, by value, H1 2011
  • 151.Share of OTC drugs and dietary supplements as a proportion of pharmacy sales value of leading pharmaceutical companies in Ukraine, by value, H1 2011
  • 152.Percentage of OTC and Rx prescriptions in Ukraine, selected manufacturers, November 2010
  • 153.Estimated market share of selected top manufacturers of OTC drugs in the Czech Republic, by value, 2010
  • 154.Estimated market share of selected top manufacturers of dietary supplements in the Czech Republic, by value,
  • 155.Estimated market shares of selected top OTC drug manufacturers in Hungary, by value, 2010
  • 156.Estimated market shares of selected top dietary supplement manufacturers in Hungary, by value, 2010
  • 157.Sales value and volume of top 10 manufacturers of OTC drugs and dietary supplements in Bulgaria, by sales value, 2010
  • 158.Market share of top 10 manufacturers of OTC products in Bulgaria, by value, 2010
  • 159.Market share of selected top manufacturers of OTC products in Bulgaria, by volume, 2010
  • 160.Share of OTC products as a proportion of the sales value of pharmaceutical distributors in Russia, by category of wholesaler, 2010
  • 161.Share of OTC products as a proportion of the sales value of pharmaceutical distributors in Russia, by category of wholesaler, Q1 2011
  • 162.Concentration of pharmaceutical wholesale in Russia, 2006-2010
  • 163.Market share of largest pharmaceutical wholesalers in Russia, by sales value, 2010
  • 164.Protek CV revenues ($ bn) and y-o-y change in Russia, 2006-H1 2011
  • 165.Share of parapharmaceuticals as a proportion of Protek CV's gross profit in Russia, 2010
  • 166.Share of cosmetics and non-drugs as a proportion of Protek CV's revenues and number of products in Russia, 2010
  • 167.SIA International revenues ($ bn) and y-o-y change in Russia, 2006-2010
  • 168.Katren revenues ($ bn) and y-o-y change in Russia, 2006-2010
  • 169.Rosta revenues ($ bn) and y-o-y change in Russia, 2007-2010
  • 170.Alliance Healthcare revenues ($ m) and y-o-y change in Russia, 2007/2008-2010/2011
  • 171.Share of parapharmaceuticals as a proportion of the sales value of pharmacy chains in Russia, by category of pharmacy chain, 2010
  • 172.Selected largest pharmacy chains in Russia, by number of outlets, August 2011
  • 173.Market share of selected largest pharmacy chains as a proportion of the pharmacy market in Russia, by sales value, 2010
  • 174.Market share of top 10 pharmacy chains in Russia, by sales value, 2003-2010
  • 175.Market share of selected largest pharmacy chains as a proportion of the pharmacy market in Russia, by sales value, H1 2011
  • 176.36,6 pharmacy chain expansion in Russia (number of units and y-o-y change), 2003-H1 2011
  • 177.36,6 sales revenues ($ m) and y-o-y change in Russia, 2004-H1 2011
  • 178.Implozia turnover ($ m) and y-o-y change in Russia, 2009-2010
  • 179.Raduga turnover ($ m) and y-o-y change in Russia, 2009-2010
  • 180.Pharmakor sales revenues ($ m) and y-o-y change in Russia, 2009-2010
  • 181.Rigla sales revenues ($ m) and y-o-y change in Russia, 2006-H1 2011
  • 182.Share of OTC drugs and parapharmaceuticals as a proportion of Rigla sales revenues in Russia, 2010 209
  • 183.A5 net revenues ($ m) and y-o-y change in Russia, 2007-2014
  • 184.Market shares of the largest players on the pharmaceutical wholesale market in Poland, by sales to pharmacies, H1 2011
  • 185.Neuca group sales revenues (€ m) and y-o-y change in Poland, 2006-H1 2011
  • 186.PGF group sales revenues (€ m) and y-o-y change, 2006-H1 2011 216
  • 187.Farmacol group sales revenues (€ m) and y-o-y change in Poland, 2006-H1 2011
  • 188.ACP Pharma wholesale revenues (€ m) and y-o-y change in Poland, 2006-H1 2011
  • 189.Turnover on the sale of OTC products in individual pharmacy locations compared to the average pharmacy turnover in Poland (%), 2010
  • 190.Average annual sales of OTC medicines by pharmacies in Poland (PLN '000): loyalty programme pharmacies, private pharmacies and chain pharmacies, 2009-2010
  • 191.Selected largest pharmacy chains in Poland, by number of outlets, August 2011
  • 192.ACP Pharma retail sales revenues in Poland (€ m) and y-o-y change, 2006-H1 2011
  • 193.Revenues and net profit/loss of BRL Center in Poland (€ m), 2004-2009
  • 194.Revenues and net profit/loss of Euro Apteka in Poland (€ m), 2003-2009
  • 195.The most popular online pharmacies in Poland, by number of users (real users in '000), December 2010
  • 196.Market shares of the largest players on the pharmaceutical wholesale market in Ukraine, by sales to pharmacies, 2010
  • 197.Concentration of pharmaceutical wholesale in Ukraine, market share by sales value, H1 2009-H1 2011 229
  • 198.BaDM sales ($ m) and y-o-y change in Ukraine, 2009-2010
  • 199.Optima-Pharm sales ($ m) and y-o-y change in Ukraine, 2009-2010
  • 200.Alba Ukraine sales ($ m) and y-o-y change in Ukraine, 2009-2010
  • 201.VVS sales ($ m) and y-o-y change in Ukraine, 2009-2010 232
  • 202.Fra-M sales ($ m) and y-o-y change in Ukraine, 2009-2010 233
  • 203.Venta sales ($ m) and y-o-y change in Ukraine, 2009-2010 233
  • 204.Share of OTC products as a proportion of Venta's portfolio in Ukraine, 2010
  • 205.Share of OTC products as a proportion of Venta's sales in Ukraine, by value and volume, 2010
  • 206.Number of pharmacies, pharmacy points and pharmacy kiosks in Ukraine, January 2002-June 2011
  • 207.Number of pharmacy outlets in Ukraine, by category, June 2011
  • 208.Concentration of pharmacy chains in Ukraine and in particular regions, market share by sales value, 2010
  • 209.Market share of selected largest pharmacy chains in Ukraine, by sales value, Q1-Q3 2010
  • 210.Sales revenues of selected largest pharmacy chains in Ukraine (UAH m), Q1-Q3 2010
  • 211.Selected largest pharmacy chains in Ukraine, by number of outlets, August 2011
  • 212.Numbers of medicine distribution licence holders in the Czech Republic, 2004-June 2011
  • 213.Market share of pharmaceutical wholesalers in the Czech Republic, by value, 2002-2010
  • 214.Phoenix Pharma sales revenues (€ m) and y-o-y change in the Czech Republic, February 2005-January 2010
  • 215.Alliance Healthcare sales revenues (€ m) and y-o-y change in the Czech Republic, April 2007-March 2011
  • 216.Share of OTC products as a proportion of Alliance Healthcare revenues in the Czech Republic, H1 2011
  • 217.Pharmos sales revenues (€ m) and y-o-y change in the Czech Republic, 2005-2010
  • 218.Gehe Pharma Prague sales revenues (€ m) and y-o-y change in the Czech Republic, 2006-2010
  • 219.Number of pharmacies and pharmacy points in the Czech Republic, 2000-Q1 2011
  • 220.Selected largest pharmacy chains in the Czech Republic, by number of outlets, August 2011
  • 221.Ceska lekarna sales revenues (€ m) and y-o-y change in the Czech Republic, 2007-2009
  • 222.Revenues and gross profit/loss of EuroPharm in the Czech Republic (€ m), 2006-January 2010
  • 223.Lloyds sales revenues (€ m) and y-o-y change in the Czech Republic, 2006-2010
  • 224.Number of OTC medicines available at places other than pharmacies in the Czech Republic, 2004-2009 and February 2011 254
  • 225.Market shares of largest players on the pharmaceutical wholesale market in Romania, by sales value to pharmacies and hospitals, 2010 256
  • 226.Mediplus sales revenues (€ m) and y-o-y change in Romania, 2003-2010
  • 227.FarmExpert sales revenues (€ m) and y-o-y change in Romania, 2006-2011
  • 228.Fildas Trading revenues (€ m) and y-o-y change in Romania, 2005-2010
  • 229.Polisano sales revenues (€ m) and y-o-y change in Romania, 2002-2010
  • 230.Polisano sales breakdown in Romania, by distribution channel, 2003 and 2009
  • 231.Farmexim sales revenues (€ m) and y-o-y change in Romania, 2006-2011
  • 232.Farmexim net profit (€ m) and y-o-y change in Romania, 2009-2011
  • 233.ADM Farm sales revenues (€ m) and y-o-y change in Romania, 2002-2011
  • 234.Number of pharmacies in Romania, by location, 2010 263
  • 235.Selected largest pharmacy chains in Romania, by number of outlets, October 2011
  • 236.Sensiblu sales revenues (€ m) and y-o-y change in Romania, 2003-2010
  • 237.Farmaplanet revenue (€ m) and y-o-y change in Romania, 2006-2009
  • 238.Catena sales revenues (€ m) and y-o-y change in Romania, 2007-2010
  • 239.Dona sales revenues (€ m) and y-o-y change in Romania, 2007-2010 268
  • 240.Ropharma sales revenues (€ m) and y-o-y change in Romania, 2007-H1 2011
  • 241.Hermes Pharma revenues (€ m) and y-o-y change in Romania, 2007-2010
  • 242.Help Net sales revenues (€ m) and y-o-y change in Romania, 2002-2011
  • 243.Remedia sales revenues (€ m) and y-o-y change in Romania, 2009-2011
  • 244.Gedeon Richter sales revenues (€ m) and y-o-y change in Romania, 2007-2010
  • 245.Farmacia Richter revenues (€ m) and y-o-y change in Romania, 2007-2010
  • 246.Centrofarm sales revenues (€ m) and y-o-y change in Romania, 2003-H1 2011
  • 247.Estimated market shares of selected largest players on the pharmaceutical wholesale market in Hungary, by sales to pharmacies and hospitals, 2010
  • 248.Hungaropharma sales revenues (€ m) and y-o-y change, 2006-2010
  • 249.Phoenix Pharma sales revenues (€ m) and y-o-y change in Hungary, 2006/2007-2010/2011
  • 250.Viridis Pharma sales revenues (€ m) and y-o-y change in Hungary, 2007-2009
  • 251.Number of pharmacy outlets in Hungary, by category, July 2011
  • 252.Selected largest pharmacy chains in Hungary, by number of outlets, August 2011
  • 253.Pharmacies belonging to Alma pharmacy chain in Hungary, by category, August 2011
  • 254.Share of OTC products as a proportion of Pingvin Patika revenues in Hungary, 2010
  • 255.Number of private wholesalers in Bulgaria, 2007-2010
  • 256.Market shares of largest players on the pharmaceutical wholesale market in Bulgaria, pharmacy and hospital sales, 2010
  • 257.Libra revenues (€ m) and y-o-y change in Bulgaria, 2007-2010
  • 258.Sting revenues (€ m) and y-o-y change in Bulgaria, 2006-2009
  • 259.Sopharma Trading sales revenues and net profit in Bulgaria (€ m), 2007-H1 2011
  • 260.Higia revenues (€ m) and y-o-y change in Bulgaria, 2007-2010
  • 261.Number of private, state-owned and hospital pharmacies in Bulgaria, 2007-2010
  • 262.Average annual turnover of pharmacies in Bulgaria (BGN '000) and y-o-y change, 2008-2010
  • 263.Selected largest pharmacy chains in Bulgaria, by number of outlets, August 2011
  • 264.Number of pharmacy outlets operated by SCS Franchise in Bulgaria, by name, August 2011
  • 265.Market share of pharmaceutical wholesalers in Slovakia, by value, 2008-2010
  • 266.Phoenix Pharma sales revenues (€ m) and y-o-y change in Slovakia, February 2005-January 2010
  • 267.Unipharma sales revenues (€ m) and y-o-y change in Slovakia, 2004-2009
  • 268.Med-Art sales revenues (€ m) and y-o-y change in Slovakia, 2005-2009
  • 269.Inforama sales revenues (€ m) and y-o-y change in Slovakia, 2004-October 2010
  • 270.Selected largest pharmacy chains in Slovakia, by number of outlets, August 2011
  • 271.Dr. Max revenues (€ m) and y-o-y change in Slovakia, 2007-2010
  • 272.Comparison of non-pharmacy sales of medicines in CEE countries, 2011
  • 273.Comparison of online sales of medicines in CEE countries, 2011
  • 274.Mean population to pharmacy ratio in selected CEE countries, 2011
  • 275.Countries with the highest GDP growth in the CEE region (%), 2004-2010
  • 276.Countries with the lowest GDP growth in the CEE region (%), 2004-2010
  • 277.Total GDP in CEE countries ($ bn), 2004-2010
  • 278.GDP of CEE countries analysed ($ bn) and its share in total GDP of the region, 2010
  • 279.Countries with the lowest inflation rates in the CEE region (%), 2004-2010
  • 280.Countries with the highest inflation rates in the CEE region (%), 2004-2010
  • 281.Countries with the lowest unemployment rates in the CEE region (%, yearly average), 2004-2010
  • 282.Countries with the highest unemployment rates in the CEE region (%, yearly average), 2004-2010
  • 283.Populations of CEE countries analysed (million of inhabitants), 2010
  • 284.Male life expectancy at birth in CEE countries analysed, 1990 and 2009
  • 285.Female life expectancy at birth in CEE countries analysed, 1990 and 2009
  • 286.Adults of more than 15 years of age who are overweight and obese in CEE countries analysed (% of population), 2010
  • 287.Incidence of alcohol consumption in CEE in comparison with EU average, last 12 months, 2009
  • 288.Incidence of alcohol consumption in selected CEE countries, by country, by incidence, 2009
  • 289.Amount of alcohol drunk in selected CEE countries, by country, by amount, 2009
  • 290.Incidence of smoking among adults (% of population) in selected CEE countries, 2009
  • 291.Incidence of smoking among adults (% of population) in selected CEE countries, by gender, 2009

List of tables

  • 1.Annual average exchange rates used for this report (euro to national currency), 2006-2010
  • 2.Value and volume of OTC drugs market in Russia, 2010
  • 3.Value and volume of dietary supplements pharmacy market in Russia, 2010
  • 4.Leading OTC drugs and dietary supplements as a proportion of the out-of-the-pocket plant-based liver protector market in Russia, in terms of value, Q1-Q3 2010
  • 5.Leading OTC brands by pharmaceutical representative promotions to pharmacists, 2010
  • 6.Average prices per package and per one tablet of best-selling domestic OTC headache drugs in Ukraine, Q1 2011
  • 7.Average prices per package and per one tablet of best-selling foreign OTC headache drugs in Ukraine, Q1 2011
  • 8.Selected best-selling OTC drugs in Ukraine, in terms of value, 2010
  • 9.Selected best-selling OTC drugs in Ukraine, in terms of value, H1 2011
  • 10.Top 10 best-selling OTC domestic headache drugs in Ukraine, in terms of value, Q1 2011
  • 11.Top 10 best-selling OTC foreign headache drugs in Ukraine, in terms of value, Q1 2011
  • 12.Top 10 best-selling dietary supplements in Ukraine, pharmacy sales, in terms of value, 2010
  • 13.Best-selling dietary supplements in individual regions of Ukraine, pharmacy sales, in terms of value, January-August 2010
  • 14.Top 10 best-selling dietary supplements in Ukraine, pharmacy sales, in terms of value, H1 2011
  • 15.Changes in medicinal status (Rx to OTC switch) in the Czech Republic, 2010-H1 2011
  • 16.Best-selling OTC products in the Czech Republic, wholesale sales, by volume, 2010
  • 17.Top two best-selling OTC drugs in Romania, by sales value, Q1 2010 and Q1 2011
  • 18.Top six best-selling OTC drugs in Romania (million of packages), H1 2011
  • 19.Best selling OTC drugs in Hungary, by value, 2010
  • 20.Best selling OTC analgesics in Hungary, by volume, Q3 2010, Q4 2010 and January 2011
  • 21.Best selling OTC analgesics in Hungary, by value, Q3 2010, Q4 2010 and January 2011
  • 22.Average prices of best-selling OTC drugs per package in Bulgaria, 2010
  • 23.Average prices of best-selling dietary supplements per package in Bulgaria, 2010
  • 24.Top 10 best-selling OTC drugs in Bulgaria, by sales value, 2010
  • 25.Selected best-selling OTC drugs in Bulgaria, by sales volume, 2010
  • 26.Top 10 best-selling dietary supplements in Bulgaria, by sales value, 2010
  • 27.Top 10 best-selling OTC drugs in Slovakia, by value, 2010
  • 28.Top 10 best-selling OTC drugs in Slovakia, by value, H1 2011
  • 29.Top 10 best-selling OTC drugs in Slovakia, by volume, 2010
  • 30.Top 10 best-selling OTC drugs in Slovakia, by volume, H1 2011
  • 31.Leading advertisers of OTC products in the Czech Republic, by amount spent, H1 2010 and H1 2011
  • 32.Leading advertisers of dietary supplements in the Czech Republic, by amount spent, 2009-2010
  • 33.10 top brands of OTC drugs in terms of advertising spending in the Czech Republic, by amount spent, H1 2010 and H1 2011
  • 34.Leading TV advertisers of OTC products in the Czech Republic, by amount spent, 2009-2010
  • 35.Leading radio advertisers of OTC products in the Czech Republic, by amount spent, 2009-2010
  • 36.Leading press advertisers of OTC products in the Czech Republic, by amount spent, 2009-2010
  • 37.Leading outdoor and out-of-home TV advertisers of OTC products in the Czech Republic, by amount spent, 2009-2010
  • 38.Leading advertisers of OTC brands in Hungary, by amount spent, 2010
  • 39.Leading TV advertisers of OTC brands in Hungary, by amount spent, 2010
  • 40.Data on SUKL activity in the area of drug advertising in Slovakia, 2007-2010
  • 41.Top 10 manufacturers of OTC drugs in Slovakia, by value, 2010
  • 42.Top 10 manufacturers of OTC drugs in Slovakia, by value, H1 2011 191
  • 43.Top 10 manufacturers of OTC drugs in Slovakia, by volume, 2010
  • 44.Top 10 manufacturers of OTC drugs in Slovakia, by volume, H1 2011
  • 45.GDP growth in CEE countries analysed (%), 2004-2010
  • 46.CPI in CEE countries analysed (%), 2004-2010
  • 47.Unemployment rates in CEE countries analysed (%, yearly average), 2004-2010
  • 48.Gross average monthly wages in CEE countries analysed (€ ), 2004-2010 318
Show More
Pricing
Get Notified
Email me when related reports are published